Hecht SS - Search Results

1

Changes in Biomarkers of Tobacco Exposure among Cigarette Smokers Transitioning to ENDS Use: The Population Assessment of Tobacco and Health Study, 2013-2015.

Anic GM, Rostron BL, Hammad HT, van Bemmel DM, Del Valle-Pinero AY, Christensen CH, Erives G, Faulcon LM, Blount BC, Wang Y, Wang L, Bhandari D, Calafat AM, Kimmel HL, Everard CD, Compton WM, Edwards KC, Goniewicz ML, Wei B, Hyland A, Hatsukami DK, Hecht SS, Niaura RS, Borek N, Ambrose BK, Chang CM. Anic GM, et al. Among authors: hecht ss. Int J Environ Res Public Health. 2022 Jan 27;19(3):1462. doi: 10.3390/ijerph19031462. Int J Environ Res Public Health. 2022. PMID: 35162490 Free PMC article.

2

Tobacco and cancer: approaches using carcinogen biomarkers and chemoprevention.

Hecht SS. Hecht SS. Ann N Y Acad Sci. 1997 Dec 29;833:91-111. doi: 10.1111/j.1749-6632.1997.tb48596.x. Ann N Y Acad Sci. 1997. PMID: 9616743 Review.

3

Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.

Hecht SS, Carmella SG, Chen M, Dor Koch JF, Miller AT, Murphy SE, Jensen JA, Zimmerman CL, Hatsukami DK. Hecht SS, et al. Cancer Res. 1999 Feb 1;59(3):590-6. Cancer Res. 1999. PMID: 9973205

4

Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl)butanoic acid in human urine: A substantial pathway of nicotine metabolism.

Hecht SS, Hatsukami DK, Bonilla LE, Hochalter JB. Hecht SS, et al. Chem Res Toxicol. 1999 Feb;12(2):172-9. doi: 10.1021/tx980214i. Chem Res Toxicol. 1999. PMID: 10027795

5

Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use.

Hecht SS, Carmella SG, Ye M, Le KA, Jensen JA, Zimmerman CL, Hatsukami DK. Hecht SS, et al. Cancer Res. 2002 Jan 1;62(1):129-34. Cancer Res. 2002. PMID: 11782369

6

Ethylation and methylation of hemoglobin in smokers and non-smokers.

Carmella SG, Chen M, Villalta PW, Gurney JG, Hatsukami DK, Hecht SS. Carmella SG, et al. Among authors: hecht ss. Carcinogenesis. 2002 Nov;23(11):1903-10. doi: 10.1093/carcin/23.11.1903. Carcinogenesis. 2002. PMID: 12419839

7

Preliminary study on reducing oral moist snuff use.

Hatsukami DK, Edmonds A, Schulte S, Jensen J, Le CT, Losey L, Carmella SG, Hecht SS. Hatsukami DK, et al. Among authors: hecht ss. Drug Alcohol Depend. 2003 May 21;70(2):215-20. doi: 10.1016/s0376-8716(03)00006-1. Drug Alcohol Depend. 2003. PMID: 12732415 Clinical Trial.

8

Biomarkers of tobacco exposure or harm: application to clinical and epidemiological studies. 25-26 October 2001, Minneapolis, Minnesota.

Hatsukami DK, Hecht SS, Hennrikus DJ, Joseph AM, Pentel PR. Hatsukami DK, et al. Among authors: hecht ss. Nicotine Tob Res. 2003 Jun;5(3):387-96. doi: 10.1080/1462220031000094222. Nicotine Tob Res. 2003. PMID: 12791522

9

Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.

Hecht SS, Murphy SE, Carmella SG, Zimmerman CL, Losey L, Kramarczuk I, Roe MR, Puumala SS, Li YS, Le C, Jensen J, Hatsukami DK. Hecht SS, et al. J Natl Cancer Inst. 2004 Jan 21;96(2):107-15. doi: 10.1093/jnci/djh016. J Natl Cancer Inst. 2004. PMID: 14734700 Clinical Trial.

10

Effects of reduced cigarette smoking on levels of 1-hydroxypyrene in urine.

Hecht SS, Carmella SG, Le KA, Murphy SE, Li YS, Le C, Jensen J, Hatsukami DK. Hecht SS, et al. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):834-42. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15159317 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

767 results

Search Page